Respiratory Syncytial Virus, Human
"Respiratory Syncytial Virus, Human" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of PNEUMOVIRUS and an important cause of lower respiratory disease in infants and young children. It frequently presents with bronchitis and bronchopneumonia and is further characterized by fever, cough, dyspnea, wheezing, and pallor.
| Descriptor ID |
D018113
|
| MeSH Number(s) |
B04.820.455.600.670.600.750.730
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Respiratory Syncytial Virus, Human".
Below are MeSH descriptors whose meaning is more specific than "Respiratory Syncytial Virus, Human".
This graph shows the total number of publications written about "Respiratory Syncytial Virus, Human" by people in this website by year, and whether "Respiratory Syncytial Virus, Human" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 2 | 3 |
| 1999 | 4 | 2 | 6 |
| 2000 | 2 | 0 | 2 |
| 2001 | 1 | 0 | 1 |
| 2003 | 4 | 0 | 4 |
| 2004 | 2 | 1 | 3 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 3 | 0 | 3 |
| 2008 | 2 | 0 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 4 | 0 | 4 |
| 2013 | 4 | 0 | 4 |
| 2014 | 6 | 1 | 7 |
| 2015 | 3 | 0 | 3 |
| 2016 | 5 | 3 | 8 |
| 2017 | 6 | 1 | 7 |
| 2018 | 5 | 1 | 6 |
| 2019 | 4 | 0 | 4 |
| 2020 | 5 | 0 | 5 |
| 2021 | 9 | 3 | 12 |
| 2022 | 6 | 0 | 6 |
| 2023 | 9 | 0 | 9 |
| 2024 | 4 | 0 | 4 |
| 2025 | 4 | 7 | 11 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Respiratory Syncytial Virus, Human" by people in Profiles.
-
Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults With Respiratory Syncytial Virus. Clin Infect Dis. 2026 Mar 17; 82(3):e561-e570.
-
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoprotein. Cell Rep Med. 2026 Feb 17; 7(2):102564.
-
Assessing Clinical Improvement of Infants Hospitalized for Respiratory Syncytial Virus-Related Critical Illness. J Infect Dis. 2025 Dec 20; 232(6):1283-1291.
-
Long-Term Illness in Adults Hospitalized for Respiratory Syncytial Virus Disease, United States, February 2022-September 2023. Emerg Infect Dis. 2025 12; 31(14):20-29.
-
The path to equitable respiratory syncytial virus prevention for infants: challenges and opportunities for global implementation. Lancet Glob Health. 2025 Dec; 13(12):e2165-e2174.
-
Single cell sequencing analysis of respiratory syncytial virus-infected pediatric and adult human nose organoids reveals age differences, proliferative diversity and identifies novel cellular tropism. J Infect. 2025 Oct; 91(4):106617.
-
Human Metapneumovirus and Respiratory Syncytial Virus in Children: A Comparative Analysis. Pediatrics. 2025 Sep 01; 156(3).
-
Oral dosing of the nucleoside analog obeldesivir is efficacious against RSV infection in African green monkeys. Nat Commun. 2025 Jul 11; 16(1):6437.
-
Complete genomic characterization of global pathogens respiratory syntical virus and human norovirus using probe based capture enrichment. Sci Rep. 2025 Jul 01; 15(1):20526.
-
Evaluation of a monoclonal antibody against respiratory syncytial virus, clesrovimab, in infants and children: Comprehensive rationale and study design for the late-stage clinical trials. Contemp Clin Trials. 2025 Oct; 157:107995.